Amarantus Bioscience Holdings Inc (AMBS)

[JPetroInc]

4 weeks left & no $2.5-Mil. LOI financing

http://www.evaluategroup.com/Universal/View.aspx?type=Story&id=699135

UPDATE REGARDING THE LETTER OF INTENT

Following SeD Biomedical's preliminary due diligence, SeD Biomedical has informed Amarantus ' management of strategic measures that must be met by creditors and certain other parties as a condition for any investment, loan or asset injection by SeD Biomedical.

Neither SeD Biomedical, Amarantus , nor any individuals or entities affiliated with SeD Biomedical and Amarantus (including the management, directors and shareholders of SeD Biomedical and Amarantus ) is able to guarantee Amarantus ' management's ability to successfully negotiate with creditors or other parties, raise funds or successfully implement a new strategic direction for Amarantus . In the event that creditors and certain other parties decline to participate in the planned restructuring of liabilities to be developed by Amarantus ' management under the supervision of the Board, and to execute such releases as may be required in connection with such restructuring, SeD Biomedical reserves the right to terminate the LOI.

"We understand financial engineering Shelly"